Scancell Holdings (SCLP)

 

Latest News

Holding(s) in Company

RNS Number: 8506F Scancell Holdings Plc 22 May 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Scancell Holdings plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisit...

Holding(s) in Company

RNS Number: 7114F Scancell Holdings Plc 19 May 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Scancell Holdings plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acquis...

Holding(s) in Company

RNS Number: 6026F Scancell Holdings Plc 19 May 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Scancell Holdings PLC 2. Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights Yes An acqu...

Results of Placing

RNS Number: 8917E Scancell Holdings Plc 11 May 2017 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATION...

All News

DateHeadlineSource
22-05-17Holding(s) in CompanyRNS
19-05-17Holding(s) in CompanyRNS
19-05-17Holding(s) in CompanyRNS
11-05-17Results of PlacingRNS
11-05-17Scancell proposes raising up to £5.0mStockMarketWire
11-05-17Proposed Placing to Raise up to ?5.0 millionRNS
13-04-17Scancell changes registered officeStockMarketWire
13-04-17Change of Registered OfficeRNS
20-03-17Immuno-Oncology Summit Europe 2017RNS
13-03-17Scancell eyes fundraising for Phase II SCIB1 trialStockMarketWire
13-03-17Hardman Research: SCIB development updateRNS
01-03-17Holding(s) in CompanyRNS
31-01-17Scancell widens H1 pretax lossStockMarketWire
31-01-17Interim ResultsRNS
30-01-17Scancell in partnership to advance lung cancer clinical trialsStockMarketWire
30-01-17Partnership to Advance Lung Cancer Clinical TrialsRNS
03-01-17Research Update - AmendmentRNS
03-01-17Scancell Holdings issues research updateStockMarketWire
03-01-17Research UpdateRNS
14-11-16World Immunotherapy Congress and Biotech and MoneyRNS
18-10-16Results of AGMRNS
10-10-16Preparing SCIB2 for clinical study in lung cancerRNS
26-09-16Hardman Report: New frontiers in T-cell activationRNS
23-09-16Notice of AGM - AmendmentRNS
23-09-16Scancell Holdings schedules AGMStockMarketWire
23-09-16Notice of AGMRNS
16-09-16Scancell widens H1 pretax loss StockMarketWire
16-09-16Final ResultsRNS
07-09-16NewsMakers in the Biotech Industry ConferenceRNS
22-08-16Appointment of Non-Executive DirectorRNS
21-07-16Eurogentec manufacturing agreementRNS
20-07-16Scancell extends Ichor commercial optionStockMarketWire
20-07-16Extension to Ichor Commercial OptionRNS
13-07-16Peer-reviewed publication on Moditope? platformRNS
06-07-16Scancell notes SCIB1 compelling survival data StockMarketWire
06-07-16SCIB1 compelling survival data in melanomaRNS
29-06-16Second Price Monitoring ExtnRNS
29-06-16Price Monitoring ExtensionRNS
17-06-16FTSE flies amid Brexit pause as gold, oil off highsStockMarketWire
17-06-16Scancell suspends dosing of SCIB1 immediatelyStockMarketWire

RSS feeds

  • Editorial news feed for LSE:SCLP Editorial
  • Regulatory news feed for LSE:SCLP Regulatory